Global Induced Pluripotent Stem Cell ((iPSC) Market to Reach $0 Thousand by 2027
Abstract: What’s New for 2022?? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.
New York, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Induced Pluripotent Stem Cell (iPSC) Industry" - https://www.reportlinker.com/p05798831/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one yearGlobal Induced Pluripotent Stem Cell ((iPSC) Market to Reach $0 Thousand by 2027
- In the changed post COVID-19 business landscape, the global market for Induced Pluripotent Stem Cell ((iPSC) estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$0 Thousand by 2027, growing at a CAGR of -100% over the analysis period 2020-2027. Vascular Cells, one of the segments analyzed in the report, is projected to record a -100% CAGR and reach US$0 Thousand by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cardiac Cells segment is readjusted to a revised -100% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $629.2 Million, While China is Forecast to Grow at -100% CAGR
- The Induced Pluripotent Stem Cell ((iPSC) market in the U.S. is estimated at US$629.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$0 Thousand by the year 2027 trailing a CAGR of -100% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -100% and -100% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately -100% CAGR.Neuronal Cells Segment to Record -100% CAGR
- In the global Neuronal Cells segment, USA, Canada, Japan, China and Europe will drive the -100% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$188.9 Million in the year 2020 will reach a projected size of US$0 Thousand by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Select Competitors (Total 51 Featured)
Axol Bioscience Ltd.
Cynata Therapeutics Limited
Evotec SE
Fate Therapeutics, Inc.
FUJIFILM Cellular Dynamics, Inc.
Ncardia
Pluricell Biotech
REPROCELL USA, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ViaCyte, Inc.
Read the full report: https://www.reportlinker.com/p05798831/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
Induced Pluripotent Stem Cells (iPSCs) Market Gains from
Increasing Use in Research for COVID-19
Studies Employing iPSCs in COVID-19 Research
Stem Cells, Application Areas, and the Different Types: A Prelude
Applications of Stem Cells
Types of Stem Cells
Induced Pluripotent Stem Cell (iPSC): An Introduction
Production of iPSCs
First & Second Generation Mouse iPSCs
Human iPSCs
Key Properties of iPSCs
Transcription Factors Involved in Generation of iPSCs
Noteworthy Research & Application Areas for iPSCs
Induced Pluripotent Stem Cell ((iPSC) Market: Growth Prospects
and Outlook
Drug Development Application to Witness Considerable Growth
Technical Breakthroughs, Advances & Clinical Trials to Spur
Growth of iPSC Market
North America Dominates Global iPSC Market
Competition
Recent Market Activity
Select Innovation/Advancement
Induced Pluripotent Stem Cell (iPSC) - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Axol Bioscience Ltd. (UK)
Cynata Therapeutics Limited (Australia)
Evotec SE (Germany)
Fate Therapeutics, Inc. (USA)
FUJIFILM Cellular Dynamics, Inc. (USA)
Ncardia (Belgium)
Pluricell Biotech (Brazil)
REPROCELL USA, Inc. (USA)
Sumitomo Dainippon Pharma Co., Ltd. (Japan)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific, Inc. (USA)
ViaCyte, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Effective Research Programs Hold Key in Roll Out of Advanced
iPSC Treatments
Induced Pluripotent Stem Cells: A Giant Leap in the Therapeutic
Applications
Research Trends in Induced Pluripotent Stem Cell Space
Worldwide Publication of hESC and hiPSC Research Papers for the
Period 2008-2010, 2011-2013 and 2014-2016
Number of Original Research Papers on hESC and iPSC Published
Worldwide (2014-2016)
Concerns Related to Embryonic Stem Cells Shift the Focus onto
iPSCs
Regenerative Medicine: A Promising Application of iPSCs
Induced Pluripotent: A Potential Competitor to hESCs?
Global Regenerative Medicine Market Size in US$ Billion for
2019, 2021, 2023 and 2025
Global Stem Cell & Regenerative Medicine Market by Product
(in %) for the Year 2019
Global Regenerative Medicines Market by Category: Breakdown
(in %) for Biomaterials, Stem Cell Therapies and Tissue
Engineering for 2019
Pluripotent Stem Cells Hold Significance for Cardiovascular
Regenerative Medicine
Leading Causes of Mortality Worldwide: Number of Deaths in
Millions & % Share of Deaths by Cause for 2017
Leading Causes of Mortality for Low-Income and High-Income
Countries
Growing Importance of iPSCs in Personalized Drug Discovery
Persistent Advancements in Genetics Space and Subsequent Growth
in Precision Medicine Augur Well for iPSCs Market
Global Precision Medicine Market (In US$ Billion) for the Years
2018, 2021 & 2024
Increasing Prevalence of Chronic Disorders Supports Growth of
iPSCs Market
Worldwide Cancer Incidence: Number of New Cancer Cases
Diagnosed for 2012, 2018 & 2040
Number of New Cancer Cases Reported (in Thousands) by Cancer
Type: 2018
Fatalities by Heart Conditions: Estimated Percentage Breakdown
for Cardiovascular Disease, Ischemic Heart Disease, Stroke,
and Others
Rising Diabetes Prevalence Presents Opportunity for iPSCs
Market: Number of Adults (20-79) with Diabetes (in Millions)
by Region for 2017 and 2045
Aging Demographics Add to the Global Burden of Chronic
Diseases, Presenting Opportunities for iPSCs Market
Expanding Elderly Population Worldwide: Breakdown of Number of
People Aged 65+ Years in Million by Geographic Region for the
Years 2019 and 2030
Growth in Number of Genomics Projects Propels Market Growth
Genomic Initiatives in Select Countries
New Gene-Editing Tools Spur Interest and Investments in
Genetics, Driving Lucrative Growth Opportunities for iPSCs:
Total VC Funding (In US$ Million) in Genetics for the Years
2014, 2015, 2016, 2017 and 2018
Launch of Numerous iPSCs-Related Clinical Trials Set to Benefit
Market Growth
Number of Induced Pluripotent Stem Cells based Studies by
Select Condition: As on Oct 31, 2020
iPSCs-based Clinical Trial for Heart Diseases
Induced Pluripotent Stem Cells for Stroke Treatment
?Off-the-shelf? Stem Cell Treatment for Cancer Enters Clinical
Trial
iPSCs for Hematological Disorders
Market Benefits from Growing Funding for iPSCs-Related R&D
Initiatives
Stem Cell Research Funding in the US (in US$ Million) for the
Years 2016 through 2021
Human iPSC Banks: A Review of Emerging Opportunities and Drawbacks
Human iPSC Banks Worldwide: An Overview
Cell Sources and Reprogramming Methods Used by Select iPSC Banks
Innovations, Research Studies & Advancements in iPSCs
Key iPSC Research Breakthroughs for Regenerative Medicine
Researchers Develop Novel Oncogene-Free and Virus-Free iPSC
Production Method
Scientists Study Concerns of Genetic Mutations in iPSCs
iPSCs Hold Tremendous Potential in Transforming Research Efforts
Researchers Highlight Potential Use of iPSCs for Developing
Novel Cancer Vaccines
Scientists Use Machine Learning to Improve Reliability of iPSC
Self-Organization
STEMCELL Technologies Unveils mTeSR? Plus
Challenges and Risks Related to Pluripotent Stem Cells
A Glance at Issues Related to Reprogramming of Adult Cells to
iPSCs
A Note on Legal, Social and Ethical Considerations with iPSCs
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2025 and % CAGR
Table 2: World 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2021 & 2025
Table 3: World Recent Past, Current & Future Analysis for
Vascular Cells by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 4: World 5-Year Perspective for Vascular Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 5: World Recent Past, Current & Future Analysis for
Cardiac Cells by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2025 and % CAGR
Table 6: World 5-Year Perspective for Cardiac Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 7: World Recent Past, Current & Future Analysis for
Neuronal Cells by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 8: World 5-Year Perspective for Neuronal Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 9: World Recent Past, Current & Future Analysis for Liver
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2025 and
% CAGR
Table 10: World 5-Year Perspective for Liver Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 11: World Recent Past, Current & Future Analysis for
Immune Cells by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2025 and % CAGR
Table 12: World 5-Year Perspective for Immune Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 13: World Recent Past, Current & Future Analysis for
Other Cell Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 14: World 5-Year Perspective for Other Cell Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 15: World Recent Past, Current & Future Analysis for
Cellular Reprogramming by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 16: World 5-Year Perspective for Cellular Reprogramming
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 17: World Recent Past, Current & Future Analysis for Cell
Culture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2025 and % CAGR
Table 18: World 5-Year Perspective for Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 19: World Recent Past, Current & Future Analysis for Cell
Differentiation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 20: World 5-Year Perspective for Cell Differentiation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 21: World Recent Past, Current & Future Analysis for Cell
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2025 and % CAGR
Table 22: World 5-Year Perspective for Cell Analysis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 23: World Recent Past, Current & Future Analysis for
Cellular Engineering by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 24: World 5-Year Perspective for Cellular Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 25: World Recent Past, Current & Future Analysis for
Other Research Methods by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 26: World 5-Year Perspective for Other Research Methods
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 27: World Recent Past, Current & Future Analysis for Drug
Development & Toxicology Testing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2025 and % CAGR
Table 28: World 5-Year Perspective for Drug Development &
Toxicology Testing by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2021 & 2025
Table 29: World Recent Past, Current & Future Analysis for
Academic Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 30: World 5-Year Perspective for Academic Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 31: World Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 32: World 5-Year Perspective for Regenerative Medicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
Table 33: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 34: World 5-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2025
III. MARKET ANALYSIS
UNITED STATES
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 36: USA 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Cell Type - Percentage Breakdown of Value Sales
for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types for the Years 2021 & 2025
Table 37: USA Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 38: USA 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Research Method - Percentage Breakdown of Value
Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 39: USA Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 40: USA 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
CANADA
Table 41: Canada Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 42: Canada 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Cell Type - Percentage Breakdown of Value
Sales for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver
Cells, Immune Cells and Other Cell Types for the Years 2021 &
2025
Table 43: Canada Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 44: Canada 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Research Method - Percentage Breakdown of
Value Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 45: Canada Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 46: Canada 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
JAPAN
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 48: Japan 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Cell Type - Percentage Breakdown of Value Sales
for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types for the Years 2021 & 2025
Table 49: Japan Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 50: Japan 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Research Method - Percentage Breakdown of Value
Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 51: Japan Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 52: Japan 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
CHINA
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 53: China Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 54: China 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Cell Type - Percentage Breakdown of Value Sales
for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types for the Years 2021 & 2025
Table 55: China Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 56: China 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Research Method - Percentage Breakdown of Value
Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 57: China Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 58: China 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
EUROPE
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 59: Europe Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2025 and % CAGR
Table 60: Europe 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2021 & 2025
Table 61: Europe Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 62: Europe 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Cell Type - Percentage Breakdown of Value
Sales for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver
Cells, Immune Cells and Other Cell Types for the Years 2021 &
2025
Table 63: Europe Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 64: Europe 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Research Method - Percentage Breakdown of
Value Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 65: Europe Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 66: Europe 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
FRANCE
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 67: France Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 68: France 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Cell Type - Percentage Breakdown of Value
Sales for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver
Cells, Immune Cells and Other Cell Types for the Years 2021 &
2025
Table 69: France Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 70: France 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Research Method - Percentage Breakdown of
Value Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 71: France Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 72: France 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
GERMANY
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 73: Germany Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 74: Germany 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Cell Type - Percentage Breakdown of Value
Sales for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver
Cells, Immune Cells and Other Cell Types for the Years 2021 &
2025
Table 75: Germany Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 76: Germany 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Research Method - Percentage Breakdown of
Value Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 77: Germany Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 78: Germany 5-Year Perspective for Induced Pluripotent
Stem Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
ITALY
Table 79: Italy Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Cell Type - Vascular
Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells
and Other Cell Types - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 80: Italy 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Cell Type - Percentage Breakdown of Value Sales
for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types for the Years 2021 & 2025
Table 81: Italy Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Research Method -
Cellular Reprogramming, Cell Culture, Cell Differentiation,
Cell Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 82: Italy 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Research Method - Percentage Breakdown of Value
Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 83: Italy Recent Past, Current & Future Analysis for
Induced Pluripotent Stem Cell (iPSC) by Application - Drug
Development & Toxicology Testing, Academic Research,
Regenerative Medicine and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2025 and % CAGR
Table 84: Italy 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
UNITED KINGDOM
Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 85: UK Recent Past, Current & Future Analysis for Induced
Pluripotent Stem Cell (iPSC) by Cell Type - Vascular Cells,
Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells and
Other Cell Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2025 and % CAGR
Table 86: UK 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Cell Type - Percentage Breakdown of Value Sales
for Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types for the Years 2021 & 2025
Table 87: UK Recent Past, Current & Future Analysis for Induced
Pluripotent Stem Cell (iPSC) by Research Method - Cellular
Reprogramming, Cell Culture, Cell Differentiation, Cell
Analysis, Cellular Engineering and Other Research Methods -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2025 and % CAGR
Table 88: UK 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Research Method - Percentage Breakdown of Value
Sales for Cellular Reprogramming, Cell Culture, Cell
Differentiation, Cell Analysis, Cellular Engineering and Other
Research Methods for the Years 2021 & 2025
Table 89: UK Recent Past, Current & Future Analysis for Induced
Pluripotent Stem Cell (iPSC) by Application - Drug Development &
Toxicology Testing, Academic Research, Regenerative Medicine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2025 and % CAGR
Table 90: UK 5-Year Perspective for Induced Pluripotent Stem
Cell (iPSC) by Application - Percentage Breakdown of Value
Sales for Drug Development & Toxicology Testing, Academic
Research, Regenerative Medicine and Other Applications for the
Years 2021 & 2025
REST OF EUROPE
Table 91: Rest of Europe Recent Past, Current & Future Analysis
for Induced Pluripotent Stem Cell (iPSC) by Cell Type -
Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells,
Immune Cells and Other Cell Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2025
and % CAGR
Table 92: Rest of Europe 5-Year Perspective for Induced
Pluripotent Stem Cell (iPSC) by Cell Type - Percentage
Breakdown of Value Sales for Vascular Cells, Cardiac Cells,
Neuronal Cells, Liver Cells, Immune Cells and Other Cell Types
for the Years 2021 & 2025
Table 93: Rest of Europe Recent Past, Current & Future Analysis
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798831/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
